StemCell Institute Inc. (TYO:7096)

Market Cap	7.99B
Revenue (ttm)	2.72B
Net Income (ttm)	198.00M
Shares Out	10.25M
EPS (ttm)	19.45
PE Ratio	40.11
Forward PE	49.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,500
Average Volume	36,940
Open	786.00
Previous Close	788.00
Day's Range	780.00 - 794.00
52-Week Range	744.00 - 1,543.00
Beta	0.52
RSI	44.68
Earnings Date	Feb 6, 2026

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of new cell-based treatments, and pharmaceuticals and medical devices. It also engages in cell contract management and transportation business; extraction, purification, processing, storage, testing and sales of biological tissue-derived components; and medical facility operation and management business. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 117
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7096

Financial Performance

In 2024, StemCell Institute's revenue was 2.68 billion, an increase of 7.98% compared to the previous year's 2.48 billion. Earnings were 385.00 million, an increase of 24.19%.